Physician profile
Erin Biro
NPI 1902065758
$7,110.54
in general payments reported to CMS, 2019-2025
19 companies · $249 in 2025
The $249 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $596 · 2020: $90.10 · 2021: $545 · 2022: $4,717 · 2023: $566 · 2024: $347 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,161.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainlab, INC. | $4,234.81 | 2022-2023 | Image Guided Surgical Device |
| Spine Wave, INC. | $1,172.96 | 2019-2025 | Spinal Implant |
| Boston Scientific Corporation | $452.09 | 2019-2024 | |
| Providence Medical Technology, INC. | $253.68 | 2021-2023 | |
| Medtronic, INC. | $209.31 | 2021-2025 | Solitaire X, Intellis Adaptivestim, Onyx 18 |
| Medtronic USA, INC. | $155.21 | 2019 | |
| Relievant Medsystems, INC. | $132.01 | 2023 | Intracept |
| Isoray, INC | $128.07 | 2019 | |
| Livanova USA, INC. | $95.00 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Depuy Synthes Sales INC. | $63.29 | 2021 | |
| Globus Medical, INC. | $33.51 | 2022 | |
| Aesculap, INC. | $30.88 | 2019 | |
| Theragen, INC. | $27.79 | 2023 | Actastim-S |
| Microvention, INC. | $26.82 | 2019 | |
| Abbott Laboratories | $25.91 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $23.08 | 2024 | Duraseal Exact Spinal Sealant System, Codman Certas, Cusa Clarity |
| Ipsen Biopharmaceuticals, INC | $18.91 | 2023 | Dysport |
| Lilly USA, LLC | $15.15 | 2025 | Kisunla, Amyvid |
| Augmedics INC. | $12.06 | 2025 | Xvision |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Biro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.